Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
© 2014 Korean Breast Cancer Society. All rights reserved. Purpose: We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and compared to the stand...
Saved in:
Main Authors: | Jitawatanarat,P., O’connor,T.L., Kossoff,E.B., Levine,E.G., Chittawatanarat,K., Ngamphaiboon,N. |
---|---|
Format: | Article |
Published: |
Korean Breast Cancer Society
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919832059&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
by: Potjana Jitawatanarat, et al.
Published: (2018) -
Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel
by: Sun, B., et al.
Published: (2014) -
Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel
by: Sun, B., et al.
Published: (2014) -
Trastuzumab-conjugated vitamin e TPGS liposomes for sustained and targeted delivery of docetaxel
by: Raju, A., et al.
Published: (2014) -
Trastuzumab-conjugated vitamin e TPGS liposomes for sustained and targeted delivery of docetaxel
by: Raju, A., et al.
Published: (2014)